Expression of a secreted fibroblast growth factor binding protein-1 (FGFBP1) in Angioproliferative kaposi sarcoma

Journal of AIDS and Clinical Research

Volumn 5, Issue 6, 2014, Pages

  Ray, Patricio E ^a   Al Attar, Ali ^b   Liu, Xue Hui ^a   Das, Jharna R ^a   Tassi, Elena ^b   Wellstein, Anton ^b  

^a GEORGE WASHINGTON UNIVERSITY   (United States)

^b GEORGETOWN UNIVERSITY   (United States)

Author keywords

Angiogenesis; Endothelial cells; FGF 2 binding; FGF 2 release; Fibroblast growth factor; HIV Tat; Kaposi's sarcoma; KS spindle cells; Pediatric AIDS

Indexed keywords

EID: 84904691058     PISSN: None     EISSN: 21556113     Source Type: Journal    
DOI: 10.4172/2155-6113.1000309     Document Type: Article

References (35)

1. Safai B (1984) Kaposi's sarcoma: a review of the classical and epidemic forms. Ann N Y Acad Sci 437: 373-382.
2. Chang Y, Cesarman E, Pessin MS, Lee F, Culpepper J, et al. (1994) Identification of herpesvirus-like DNA sequences in AIDS-associated Kaposi's sarcoma. Science 266: 1865-1869.
3. Orenstein JM, Alkan S, Blauvelt A, Jeang KT, Weinstein MD, et al. (1997) Visualization of human herpesvirus type 8 in Kaposi's sarcoma by light and transmission electron microscopy. AIDS 11: F35-45.
4. Gallo RC (1995) Human retroviruses in the second decade: a personal perspective. Nat Med 1: 753-759.
5. Ensoli B, Gendelman R, Markham P, Fiorelli V, Colombini S, et al. (1994) Synergy between basic fibroblast growth factor and HIV-1 Tat protein in induction of Kaposi's sarcoma. Nature 371: 674-680.
6. Schulze-Osthoff K, Goerdt S, Sorg C (1990) Expression of basic fibroblast growth factor (bFGF) in Kaposi's sarcoma: an immunohistologic study. J Invest Dermatol 95: 238-240.
7. Blotnick S, Peoples GE, Freeman MR, Eberlein TJ, Klagsbrun M (1994) T lymphocytes synthesize and export heparin-binding epidermal growth factorlike growth factor and basic fibroblast growth factor, mitogens for vascular cells and fibroblast: Differential production and release by CD4+ and CD8+ T cells. Proc Natl Acad Sci 91: 2890-2894.
8. Ruoslahti E, Yamaguchi Y (1991) Proteoglycans as modulators of growth factor activities. Cell 64: 867-869.
9. Goetz R, Mohammadi M (2013) Exploring mechanisms of FGF signalling through the lens of structural biology. Nat Rev Mol Cell Biol 14: 166-180.
10. Iozzo RV, San Antonio JD (2001) Heparan sulfate proteoglycans: heavy hitters in the angiogenesis arena. J Clin Invest 108: 349-355.
11. Klagsbrun M, Baird A (1991) A dual receptor system is required for basic fibroblast growth factor activity. Cell 67: 229-231.
12. Albini A, Benelli R, Presta M, Rusnati M, Ziche M, et al. (1996) HIV-tat protein is a heparin-binding angiogenic growth factor. Oncogene 12: 289-297.
13. Rusnati M, Coltrini D, Oreste P, Zoppetti G, Albini A, et al. (1997) Interactions of HIV-Tat protein with Heparin. J Biol Chem 272: 11313-11320.
14. Wu DQ, Kan MK, Sato GH, Okamoto T, Sato JD (1991) Characterization and molecular cloning of a putative binding protein for heparin-binding growth factors. J Biol Chem 266: 16778-16785.
15. Czubayko F, Smith RV, Chung HC, Wellstein A (1994) Tumor growth and angiogenesis induced by a secreted binding protein for fibroblast growth factors. J Biol Chem 269: 28243-28248.
16. Czubayko F, Liaudet-Coopman ED, Aigner A, Tuveson AT, Berchem Gj, et al. (1997) A secreted FGF-binding protein can serve as the angiogenic binding protein for fibroblast growth factors. Nat Med 3: 1137-1140.
17. Liu XH, Aigner A, Wellstein A, Ray PE (2001) Up-regulation of a fibroblast growth factor binding protein in children with renal diseases. Kidney Int 59: 1717-1728.
18. Aigner A, Ray PE, Czubayko F, Wellstein A (2002) Immunolocalization of an FGF-binding protein reveals a widespread expression pattern during different stages of mouse embryo development. Histochem Cell Biol 117: 1-11.
19. Tassi E, McDonnell K, Gibby KA, Tilan JU, Kim SE, et al. (2011) Impact of fibroblast growth factor-binding protein-1 expression on angiogenesis and wound healing. Am J Pathol 179: 2220-2232.
20. Sauter ER, Nesbit M, Tichansky D, Liu Z-j, Shirakawa T, et al.(2001) Fibroblast Growth Factor-binding protein expression changes with disease progression in clinical experimental human squamous epithelium. Int J Cancer 92: 374-381.
21. Wang W, Chen HJ, Schwartz A, Cannon PJ, Rabbani LE (1997) T cell lymphokines modulate bFGF-induced smooth muscle cell fibrinolysis and migration. Am J Physiol 272: C392-398.
22. Saksela O, Moscatelli D, Sommer A, Rifkin DB (1988) Endothelial cell-derived heparan sulfate binds basic fibroblast growth factor and protects it from proteolytic degradation. J Cell Biol 107: 743-751.
23. Vlodavsky I, Bashkin P, Ishai-Michaeli R, Chajek-Shaul T, Bar-Shavit R, et al. (1991) Sequestration and release of basic fibroblast growth factor. Ann N Y Acad Sci 638: 207-220.
24. Vlodavsky I, Eldor A, Bar-Ner M, Fridman R, Cohen IR, et al. (1988) Heparan sulfate degradation in tumor cell invasion and angiogenesis. Adv Exp Med Biol 233: 201-210.
25. Bashkin P, Doctrow S, Klagsbrun M, Svahn CM, Folkman J, et al. (1989) Basic fibroblast growth factor binds to subendothelial extracellular matrix and is released by heparitinase and heparin-like molecules. Biochemistry 28: 1737-1743.
26. Moscatelli D (1992) Basic fibroblast growth factor (bFGF) dissociates rapidly from heparan sulfates but slowly from receptors. Implications for mechanisms of bFGF release from pericellular matrix. J Biol Chem 267: 25803-25809.
27. Fridman R, Lider O, Naparstek Y, Fuks Z, Vlodavsky I, et al. (1987) Soluble antigen induces T lymphocytes to secrete an endoglycosidase that degrades the heparan sulfate moiety of subendothelial extracellular matrix. J Cell Physiol 130: 85-92.
28. Fiorelli V, Gendelman R, Samaniego F, Markham PD, Ensoli B (1995) Cytokines from activated T cells induce normal endothelial cells to acquire the phenotypic and functional features of AIDS-Kaposi's sarcoma spindle cells. J Clin Invest 95: 1723-1734.
29. Samaniego F, Markham PD, Gallo RC, Ensoli B (1995) Inflammatory cytokines induce AIDS-Kaposi's sarcoma-derived spindle cells to produce and release basic fibroblast growth factor and enhance Kaposi's sarcoma-like lesion formation in nude mice. J Immunol 154: 3582-3592.
30. Samaniego Fs, Markham PD, Gendelman R, Gallo RC, Ensoli B (1997) Inflammatory cytokines induce endothelial cells to produce and release basic fibroblast growth factor and to promote Kaposi's sarcoma-like lesions in nude mice. J Immunol 158: 1887-1894.
31. Cozzolino F, Torcia M, Lucibello M, Morbidelli L, Ziche M, et al. (1993) Interferonalpha and interleukin 2 synergistically enhance basic fibroblast growth factor synthesis and induce release, promoting endothelial cell growth. J Clin Invest 91: 2504-2512.
32. Xie X, Colberg-Poley AM, Das JR, Li J, Zhang A, et al. (2014) The basic domain of HIV-Tat transactivating protine is essential for its targeting to lipid rafts and regulation of Fibroblast Growth Factor-2 signaling in podocytes isolated from children with HIV-associated nephropathy. J Am Soc Nephrol Feb 27 [Epub ahead of print].
33. Kurtz A, Aigner A, Cabal-Manzano RH, Butler RE, Hood DR, et al. (2004) Differential regulation of a fibroblast growth factor-binding protein during skin carcinogenesis and wound healing. Neoplasia 6: 595-602.
34. Gibby KA, McDonnell K, Schmidt MO, Wellstein A (2009) A distinct role for secreted fibroblast growth factor-binding proteins in development. Proc Natl Acad Sci U S A 106: 8585-8590.
35. Xie B, Tassi E, Swift MR, McDonnell K, Bowden ET, et al. (2006) Identification of the fibroblast growth factor (FGF)-interacting domain in a secreted FGFbinding protein by phage display. J Biol Chem 281: 1137-1144.